Author

Eugenio Morelli

Candiolo Cancer InstituteORCID 0000-0002-8850-0442Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. NaughtoniD· 1 shared Akira HasegawaiD· 1 shared Alessandra LaroccaiD· 1 shared Alessandro VitrioloiD· 1 shared Alice LamboleziD· 1 shared Alok K. SharmaiD· 1 shared Amanda Piveta SchnepperiD· 1 shared Andrea VandelliiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

A. NaughtonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintAug 26, 2026

The human RNA-DNA interactome is cell type-specific and dynamic

Alice Lambolez, Pelin Sahlén, Wenjing Kang…·Giuseppe Testa

The paper maps RNA-DNA interactions in 16 human cell types, showing cell-type-specific and dynamic networks that correlate with gene regulation and disease traits.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyHaematologicaPeer-reviewedApr 23, 2026

Bedaquiline Amplifies Proteasome Inhibitor Efficacy and Overcomes Resistance in Multiple Myeloma

Michela Cumerlato, Monica Maccagno, María Labrador…·Roberto Piva

This paper identifies bedaquiline as a synergistic agent that enhances proteasome inhibitor efficacy and overcomes resistance in multiple myeloma and related B-cell malignancies.

2 citationstop 4%

humanzebrafish

𝕏 PostBluesky